Luigi Mangione, 28, is expected to change his plea to guilty on federal charges in the shooting death of UnitedHealthcare CEO Brian Thompson. The hearing is scheduled for Friday morning in Manhattan's Federal Court. Mangione had previously pleaded not guilty to federal charges of stalking resulting in the death of an executive.
A former prosecutor, David Gelman, suggested the change of plea is a calculated strategy by Mangione's legal team, intended to navigate complex legal challenges and potentially avoid a life sentence. Gelman stated that while he cannot say Mangione deserves leniency, this move could offer him a chance at freedom later in life.
Mangione is facing separate trials in both state and federal court. The federal trial was slated to begin in January, while the state trial was scheduled to commence next month. By pleading guilty in federal court, his lawyers intend to argue that the state murder charges, arising from the same incident, constitute double jeopardy, a legal principle that prevents an individual from being tried twice for the same crime under New York law.
If the guilty plea is accepted, Mangione's defense is expected to immediately file a motion to dismiss the state murder charges. The state prosecution will likely contest this, arguing that the federal stalking charges and the state murder charges are distinct. The ultimate decision on whether the state can proceed would then fall to the judge presiding over the state case.
Gelman described the competition between federal and state prosecutors to try Mangione as unusual, attributing it to the high-profile nature of the offense and the significant resources invested in apprehending him. He noted that this scenario is not typical, as prosecutors usually coordinate more closely.
Mangione was apprehended in Altoona, Pennsylvania, five days after Thompson's death in Midtown Manhattan. The arrest occurred after a McDonald's manager reported a man matching the shooter's description to 911.
Judge Margaret Garnett had previously dismissed federal murder and weapons charges against Mangione in January. However, Gelman cautioned that the judge is not bound by any plea agreement and could still impose a life sentence. Should the state case proceed, Mangione's defense may attempt to influence jury selection by seeking younger, potentially sympathetic jurors, particularly given his apparent support base and defense fund that has raised substantial amounts of money.
Earlier in the week, Mangione's lawyers withdrew a planned defense of "extreme emotional disturbance." Gelman speculated this decision was based on the advice of defense analysts who likely concluded the argument would not be effective under cross-examination.